Clinical Trials in Phoenix

Showing 3381-3400 of 14,291 trials

The Symptomatic Cerebral Cavernous Malformation Trial of REC-994

NCT05085561

This is a two-part, multi-center, randomized, double-blind, placebo-controlled study to investigate the safety, efficacy and pharmacokinetics of REC-994 (200 mg and 400 mg) compared to placebo in participants with symptomatic cerebral cavernous malformation (CCM).

Cerebral Cavernous Malformation

Recursion Pharmaceuticals Inc.62 participantsStarted Mar 2022

Phoenix, Arizona, United States • Los Angeles, California, United States • Palo Alto, California, United States +12 more locations

RECRUITINGNA< 1 mile

Primary Care Evidence-based Approach for Improving Lifelong Health

NCT06526312

This study investigates the implementation and effectiveness of the Family Check-Up 4 Health (FCU4Health) intervention in primary care settings for reducing cardiovascular disease risk in children. Through a hybrid type 3 cluster randomized factorial trial and innovative technology-based strategies integrated with Electronic Health Records, the study aims to enhance intervention fidelity and engagement. Results will inform scalable approaches to promote child and family health behaviors, improve parenting skills, and potentially reduce child BMI, contributing to significant public health impacts in addressing cardiovascular health disparities.

Clinical Trial

Arizona State University840 participantsStarted Jun 2025

Phoenix, Arizona, United States

The Symptomatic Cerebral Cavernous Malformation Trial of REC-994

Primary Care Evidence-based Approach for Improving Lifelong Health

Find Trials by Condition in Phoenix

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD)

A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate

A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma

A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433

RISE FOR HEALTH Study

A Study to Evaluate the Pharmacokinetics and Safety of INCB054707 in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese

Safety and Immunogenicity of V540B in Healthy Adults (V540B-002).

Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration

A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

SLC13A5 Deficiency Natural History Study - United States Only

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis